View PubMed Profile
Peer-Reviewed Publications

Margaret Böhlin Nolan, MD, MS

Chronic disease epidemiology, prevention and control, with particular interest in cancer and cardiovascular disease.

40+

Peer-Reviewed Papers

1000+

Citations

View Google Scholar Profile

  1. Nolan MB, Remington P, and Wegner M. Eds. Chronic Disease Prevention, Epidemiology and Control, 5th Edition. APHA Press. September, 2023.

  2. Luepker RV, Nolan MB. Cardiovascular Epidemiology. In: Boulton ML, Wallace RB, eds Boulton/Maxcy-Rosenau-Last Public Health & Preventive Medicine. 16th ed. New York, NY: McGraw-Hill; 2021. https://accessmedicine.mhmedical.com/book.aspx?bookID=3078#255959778

  1. Levine R, Nolan MB, Humphrey HJ, Woodruff JN, Rodriguez ER. The Healing Arts: University of Chicago Pritzker School of Medicine Poetry Contest. Academic Psychiatry. 2014 Dec;38(6):741-9. doi: 10.1007/s40596-014-0231-7.

  2. Kadimpati S, Nolan MB, Warner DO. Attitudes, beliefs and practices regarding electronic nicotine delivery systems in patients scheduled for elective surgery. Mayo Clinic Proceedings. 2015 Jan; 90(1):71-6.

  3. Nolan MB and Warner DO. Safety and efficacy of nicotine replacement therapy in the perioperative period: A narrative review. Mayo Clinic Proceedings. 2015. Nov;90(11):1553-61. doi: 10.1016/j.mayocp.2015.08.003.

  4. Mohammed K, Nolan MB, Rajjo T, Shah ND, Varkey P and Murad MH. Creating a Patient-centered Healthcare Delivery System: A Systematic Review of Healthcare Quality from the Patient Perspective. American Journal of Medical Quality. 2016 Jan-Feb;31(1):12-21. doi: 10.1177/1062860614545124.

  5. Nolan MB, Leischow S, Croghan I, Kadimpati S, Hanson A, Schroeder D and Warner DO. Feasibility of Electronic Nicotine Delivery Systems in Surgical Patients. Nicotine and Tobacco Research 2016 Aug;18(8):1757-62. doi: 10.1093/ntr/ntw003. PMCID: PMC5942518.

  6. Warner DO, Nolan MB, Kadimpati S, Burke M, Hanson A and Schroeder D. Quitline tobacco interventions in hospitalized patients: a randomized trial. American Journal of Preventive Medicine. 2016 Oct;51(4):473-84.

  7. Nolan MB, Martin D, Thompson R, Schroeder D, Hansen A and Warner DO. Association Between Smoking Status, Preoperative Exhaled Carbon Monoxide Levels, and Postoperative Surgical Site Infection in Patients Undergoing Elective Surgery. JAMA Surgery, 2017 May 1;152(5):476-483. doi: 10.1001/jamasurg.2016.5704. PMCID#: PMC5831446

  8. Nolan MB and Warner DO. Perioperative Tobacco Use Interventions: Putting them into practice. BMJ 2017. Sept; 358. doi: tps://doi.org/10.1136/bmj.j3340.

  9. Nolan, MB, Kemper KE, Glynn TJ, Hurt RD, and Hays TJ. Tobacco Dependence Treatment Grants: A Collaborative Approach to the Implementation of WHO Tobacco Control Initiatives. Journal of Environmental and Public Health. March 2018. PMCID: PMC5885333.

  10. Nolan MB, Borah B, Moriarty J, Warner DO. Economic analysis of a geographical cohort of hospitalized smoking patients. Mayo Clinic Proceedings, 2018 Aug;93(8):1034-1042. doi: 10.1016/j.mayocp.2018.02.022. Epub 2018 Jul 4.

  11. Nolan MB, Ridgeway J, Ghosh K, Martin D and Warner DO. Design, Implementation and Evaluation of a Smoking Cessation Intervention for Patients undergoing Surgery for Breast Cancer. Supportive Care in Cancer, September 2018.

  12. Warner DO, Nolan MB, Garcia-Marcinkiewicz A, Schultz C, Warner M, Schroeder D and Cook DA. "Adaptive Instruction and Learner Interactivity in Online Learning: A Randomized Trial," Advances in Health Sciences Education, August, 2019.

  13. Vuong, I, Wright J, Nolan MB, Eggen A, Bailey E, Strickland R, Traynor A and Downs T. “Overcoming barriers: Evidence-based strategies to increase enrollment of underrepresented populations in cancer therapeutic clinical trials—a narrative review.” Journal of Cancer Education. Nov., 2019.

  14. Nolan MB, Borah B, Moriarty J and Warner DO. Association Between Smoking Cessation and Post-Hospitalization Healthcare Costs: a Matched Cohort Analysis. BMC Health Services Research. Nov., 2019. PMCID: PMC6889662

  15. Nolan MB, Zwaga D, McCarthy DE, Kastman C, Baker TB, Zehner M, Smith SS, Fiore MC. Who are we missing with EHR-based smoking cessation treatments; a descriptive study of patients who smoke and do not regularly visit primary care clinics. J Smok Cessation. 2020;15(4):175-180. PMCID:PMC9618156.

  16. The Cancer Center Cessation Initiative Coordinating Center and Expert Advisory Panel, Rolland, B., Hohl, S.D., Minion M, Adsit R, Nolan M, Pauk D, Bernstein S., Burris JL, Cinciripini PM, Joseph A, Ostroff J, Warren G, & Fiore MC. Introduction to the Special Issue on the Cancer Center Cessation Initiative Working Groups: Improving oncology care and outcomes by including tobacco treatment. Supplement to the Journal of the National Comprehensive Cancer Network, December, 2021. https://jnccn.org/view/journals/jnccn/19/Suppl_1/article-pS1.xml?ArticleBodyColorStyles=inline%20pdf

  17. Fiore MC, Baker TB, Nolan M, Emamekhoo. (2021) Providing Cessation Treatment to Every Oncology Patient Who Smokes: An Essential Component of Cancer Care. Cancer. 2021 December 7.

  18. Hohl SD, Bird JE, Nguyen CVT, D’Angelo HD, Minion M, Pauk D, Adsit RT, Fiore M, Nolan MB, Rolland B. Operationalizing leadership and clinician buy-in to implement evidence-based tobacco treatment programs in routine oncology care; a mixed method study of the U.S. Cancer Center Cessation Initiative. Curr Oncol; 2022;29:2406-2421. PMCID: PMC9032473

  19. Rolland B, Hohl SD, Minion M, Adsit R, Nolan MB, Pauk D, Bernstein SL, Burris JL, Cinciripini PM, Joseph A, Ostroff J, Warren GW, Fiore MC. Introduction to the Cancer Center Cessation Initiative Working Groups: Improving oncology care and outcomes by including tobacco treatment. J Natl Canc Center Netw. 2021;19(Suppl 1):S1-S3. PMCID: PMC9037013.

  20. McCarthy DE, Baker TB, Zehner ME, Adsit RA, Kim N, Zwaga D, Coates K, Wallenkamp H, Nolan M, Steiner M, Skora A, Kastman C, Fiore MC. A comprehensive electronic health record-enabled smoking treatment program: Evaluating reach and effectiveness in primary care in a multiple baseline design. Preventive Medicine. 2022; 165(Pt B):107101. PMCID: PMC9990874.

  21. Nolan MB, Spicer A, Remington P, and Malecki K. Missing Out: Underutilization of Primary Care by Wisconsin Patients who Smoke and its Implications for Tobacco Treatment Access. Wisconsin Medical Journal. November, 2022.

  22. Hohl SD, Shoenbill KA, Taylor KL, Minion M, Bates-Pappas GE, Hayes RB, Nolan MB, Simmons VN, Steinberg MB, Park ER, Ashing K, Beneventi D, Sanderson Cox L, Goldstein O, King A, Kotsen C, Presant CA, Sherman SE, Sheffer CE, Warren, GW, Adsit RT, Bird JE, D’Angelo H, Fiore MC, Nguyen CVT, Pauk D, Rolland B, Rigotti NA. The impact of the COVID-19 pandemic on tobacco treatment program implementation at NCI-designated Cancer Centers. Nicotine Tob Res. 2023;25(2):345-349. PMCID:9384385

  23. Ives K, Christiansen B, Nolan MB, Kaye J and Fiore MC. Rethinking smoking cessation interventions for individuals before and after release from prison based on nine years of data: A call to action. Preventive Medicine Reports. July, 2022.

  24. Piasecki T, Smith SS, Baker TB, Slutske WS, Adsit RT, Bolt DM, Conner KL, Bernstein SL, Eng OD, Lazuk D, Gonzalez A, Jorenby DE, D’Angelo H, Kirsch JA, Williams BS, Nolan MB, Hayes-Birchler T, Kent S, Kim H, Lubanski S, Yu M, Suk Y, Cai Y, Kashyap N, Mathew JP, McMahan G, Rolland B, Tindle HA, Warren GW, An LC, Boyd AD, Brunzell DH, Carrillo V, Chen L-S, Davis JM, Deshmukh VG, Dilip D, Ellerbeck EF, Goldstein A, Iturrate E, Jose T, Khanna N, King A, Klass E, Mermelstein RJ, Tong E, Tsoh JY, Wilson KM, Theobald WE, Fiore MC. Smoking status, nicotine medication, vaccination, and COVID-19 hospital outcomes; findings from the COVID EHR Cohort at the University of Wisconsin (CEC-UW) Study. Nicotine Tob Res. 2023;25(6):1184-1193. PMCID: PMC9494410.

  25. Fiore MC, Smith SS, Adsit RT, Bolt DM, Conner KL, Bernstein SL, Eng OD, Lazuk D, Gonzalez A, Jorenby DE, D’Angelo H, Kirsch JA, Williams B, Nolan MB, Hayes-Birchler T, Kent S, Kim H, Piasecki TM, Slutske WS, Lubanski S, Yu M, Suk Y, Cai Y, Kashyap N, Mathew JP, McMahan G, Rolland B, Tindle HA, Warren GW, An LC, Boyd AD, Brunzell DH, Carrillo V, Chen L-S, Davis JM, Dilip D, Ellerbeck EF, Iturrate E, Jose T, Khanna N, King A, Klass E, Newman M, Shoenbill KA, Tong E, Tsoh JY, Wilson KM, Theobald WE, Baker TB. The first 20 months of the COVID-19 pandemic: mortality, intubation, and ICU rates among 104,590 patients hospitalized at 21 United States health systems. Plos One. 2022;17(9):e0274571. PMCID: PMC9518859

  26. Nolan MB, Piasecki TM, Smith SS, Baker TB, Fiore MC, Adsit R, Bolt D, Conner K, Bernstein S, Eng O, Lazuk D, Gonzalez A, Hayes-Birchler T, Jorenby D, D'Angelo H, Kirsch J, Williams B, Kent S, Kim H, Lubanski S, Yu M, Suk Y, Cai Y, Kashyap N, Mathew J, McMahan G, Rolland B, Tindle HA, Warren GW, Abu-el-rub N, An L, Boyd A, Brunzell D, Carrillo V, Chen L-S, Davis J, Deshmukh VG, Dilip D, Goldstein A, Ha PK, Iturrate E, Jose T, Khanna N, King A, Klass E, Lui M, Mermelstein R, Poon C, Tong E, Wilson K, Theobald WE, Slutske WS. Relations of current and past cancer with severe outcomes among 104,590 hospitalized COVID-19 patients: the COVID EHR Cohort at the University of Wisconsin. Cancer Epidemiol Biomarkers Prev. 2023;32(1):12-21. PMCID#: PMC9827105

  27. Nolan MB, Nolan ME, Piasecki TM, Fiore MC, Mortality by Age Group and Intubation Status in Adult Hospitalized Patients from 21 U.S. Hospital Systems during Three Surges of the COVID-19 Pandemic, CHEST (2023), doi: https://doi.org/10.1016/j.chest.2023.01.029.

  28. Zhao L, Nolan MB, and Remington P. Mountain Bike Injury Incidence and Risk Factors among members of a Wisconsin Bike Club. Wisconsin Medical Journal. March 31, 2023.

  29. Nolan MB, Chrenka E, Walker P, Steiner A, Knuti Rodrigues A, Michel J, Yun K, Payton C, Young J, Mamo B, Frumholtz M, DeSilva M. COVID-19 vaccine uptake among non-US-born populations in the United States, 2020–2022, Vaccine, 2024. https://doi.org/10.1016/j.vaccine.2024.04.029.

  30. Nolan MB, Chrenka E, DeSilva MB. "Time to COVID-19 Vaccine by Language, Country of Origin and Need for Interpreter". JAMA Network Open. 2024 Oct 1;7(10):e2437388. doi: 10.1001/jamanetworkopen.2024.37388. PMID: 39361282; PMCID: PMC11450518.

  31. Nolan MB, Asche SE, Barton K, Benziger CP, Ekstrom HL, Essien I, O'Connor PJ, Allen CI, Freitag LA, Kharbanda EO. Cardiometabolic Risk in Pediatric Patients with Intellectual and Developmental Disabilities. Am J Prev Med. 2024 Nov 28:S0749-3797(24)00408-2. doi: 10.1016/j.amepre.2024.11.013. Epub ahead of print. PMID: 39615766.

  32. Nolan MB, Asche SE, Barton K, Benziger CP, Ekstrom HL, Essien I, O'Connor PJ, Allen CI, Freitag LA, Kharbanda EO. Cardiometabolic Risk in Pediatric Patients with Intellectual and Developmental Disabilities. Am J Prev Med. 2024 Nov 28:S0749-3797(24)00408-2. doi: 10.1016/j.amepre.2024.11.013. PMID: 39615766.

  33. Thapa B, Schmittdiel JA, Arterburn D, Neugebauer R, Dyer W, O'Connor PJ, An J, Cassidy-Bushrow AE, Gilliam LK, Hooker SA, Nolan MB, Oshiro CES, Thomas T, Simonson G, Dombrowski SK, Rodriguez LA. Clinical and Demographic Characteristics Associated With Diabetes Remission in Six Integrated Health Care Systems: A Retrospective Cohort Study. Diabetes Care. 2025 Jul 30:dc250530. doi: 10.2337/dc25-0530. Epub ahead of print. PMID: 40734551.

  34. Neugebauer R, An J, Dombrowski SK, Oshiro C, Cassidy-Bushrow A, Gilliam L, Simonson G, Karter AJ, Bergenstal R, Finertie H, Yassin MM, Knowlton G, Lin SR, Dyer W, Pimentel N, Izadian K, Schmittdiel J, Thomas TW, Hooker SA, Nolan MB, Wright E, Aurora L, Rodriguez LA, Kaur J, Adams AS, van der Laan MJ, O'Connor PJ. Glucose-Lowering Medication Classes and Cardiovascular Outcomes in Patients With Type 2 Diabetes. JAMA Netw Open. 2025 Oct 1;8(10):e2536100. doi: 10.1001/jamanetworkopen.2025.36100. PMID: 41091469; PMCID: PMC12529185.

  35. Steiner A, Settgast A, DeSilva M, Payton C, Rodrigues KK, Nolan M, Chrenka E, Frumholtz M, Michel JJ, Stein A, Mamo B, Young J. Tetanus and diphtheria vaccination coverage and electronic health record alerts for immigrants and refugees at three United States health systems, 2017-2023. Vaccine. 2025 Oct 22;67:127881. doi: 10.1016/j.vaccine.2025.127881. PMID: 41129885.

  36. Oshiro C, Hooker S, Schmittdiel J, O'Connor P, An J, Cassidy-Bushrow A, Dombrowski SK, Nolan M, Rodriguez L, Thomas T, Neugebauer R. A Comparison of Sustained Exposure to Glucose-Lowering Medications on Weight Change over 2.5 Years. Obesity 2025 Nov 1 (Vol. 33, pp. 212-213).

  37. Jansen GP, Vazquez-Benitez G, Ehresmann K, Seburg EM, Nolan MB, Palmsten K. Comparison of Linked EHR-Pharmacy Data and Administrative Claims Data: Medication Fills During Pregnancy. Pharmacoepidemiol Drug Saf. 2025 Dec;34(12):e70271. doi: 10.1002/pds.70271. PMID: 41285557.

  38. Nolan MB. From the Archive: Reflections on “Obesity Relationships With Community Design, Physical Activity, and Time Spent in Cars” by Lawrence D. Frank, Martin A. Andresen, and Thomas L. Schmid. American Journal of Preventive Medicine. 2026 Jan 1;70(1).

  39. Hooker SA, Neugebauer RS, Schmittdiel JA, An J, Cassidy-Bushrow AE, Dombrowski SK, Oshiro CES, Bergenstal R, Gilliam LK, Nolan MB, Thomas T, Rossom RC, Kaur J, Finertie H, Yassin M, Lin S, Izadian K, O'Connor PJ. Comparative safety of glucose-lowering medications on depression in adults with type 2 diabetes. Diabetes Obes Metab. 2026 Jan 2. doi: 10.1111/dom.70415. PMID: 41479367.

  40. Rai A, Marshall J, Nandyala S, Her M, Agan AA, Huang TY, Rodriguez-Watson C, Clary A, Diessner B, Nolan MB, Djibo DA, DeVries A, Daniels K, Zhang X, Wang T, Gantz I, Shankar R, Zale MM, Ejelonu P, Frederich R, Masiukiewicz U, Toh S. Post-authorization safety study to assess the risk of diabetic ketoacidosis among type 2 diabetes mellitus patients treated with ertugliflozin compared to patients treated with other antihyperglycaemic agents in a Medicare and Medicaid population. Diabet Med. 2026 Feb 9:e70208. doi: 10.1111/dme.70208. PMID: 41662384.

  41. Adimadhyam S, Luyts D, Oraichi D, Deraedt Q, Pircon JY, Bilker WB, Agan AA, Rajbhandari R, Carbonari DM, Djibo DA, Wang X, Nolan MB, DeVries A, Selvan M, Ma Q, Wentz AE, Daniels K, Platt R, Lo Re V 3rd, Cocoros NM. Postmarketing safety surveillance for GSK's AS01E-adjuvanted respiratory syncytial virus prefusion F protein-based vaccine in the USA: protocol for a non-interventional postauthorisation safety study. BMJ Open. 2026 Mar 19;16(3):e117236. doi: 10.1136/bmjopen-2026-117236. PMID: 41856590; PMCID: PMC13007074.

  42. Dombrowski SK, An J, Huang X, Lewis M, Hayduk VA, Neugebauer R, O'Connor PJ, Schmittdiel J, Hooker SA, Karter AJ, Oshiro CES, Cassidy-Bushrow AE, Nance N, Nolan MB, Gilliam LK, Graham J, Wright EA. Medication adherence and persistence of newly-initiated medications in older adults with diabetes. J Am Pharm Assoc (2003). 2026 Mar 16:103075. doi: 10.1016/j.japh.2026.103075. PMID: 41850681.

  43. Shinde MU, Shapiro K, Hou L, Coughlin K, Madow AM, Shebl FM, Bright P, Pocobelli G, Ralston JD, Graham VF, Nolan MB, Binswanger IA, Pratt N, Hua W, Cocoros NM, Perez-Vilar S. Identifying COVID-19 Disease Severity in Real-World Data: Implications for Medical Product Effectiveness Studies. Pharmacoepidemioly Drug Saf. 2026 Apr;35(4):e70363. doi: 10.1002/pds.70363. PMID: 41980592.

PUBLICATIONS [In Press or Process]

  1. Dombrowski SK, An J, Lewis M, Hayduk VA, Neugebauer R, O’Connor PJ, Rodriguez LA, Schmittdiel J, Hooker SA, Karter AJ, Oshiro CES, Cassidy-Bushrow AE, Nolan MB, Gilliam, Graham J, Wright EA. Trends in Annual Medication Possession in Older Adults with Type 2 Diabetes. Submitted to JMCP February 2026.

  2. Nolan MB, Knowlton G, Neugebauer RS, Hooker SA, Cassidy-Bushrow AE, Dombrowski SK, Kaur J, Oshiro CES, An J, O’Connor PJ. Cardiovascular Outcomes of Glucose-lowering Medications by Smoking Status. Diabetes, Obesity and Metabolism. Under revision. July 2026.

Peer-reviewed publications

Textbooks

Full Bibliography